Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Quidel Cp (QDEL)

Quidel Cp (QDEL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,389,831
  • Shares Outstanding, K 41,633
  • Annual Sales, $ 1,662 M
  • Annual Income, $ 810,290 K
  • 60-Month Beta -0.07
  • Price/Sales 3.62
  • Price/Cash Flow 6.57
  • Price/Book 4.19
Trade QDEL with:

Options Overview

Details
  • Implied Volatility 55.86%
  • Historical Volatility 40.25%
  • IV Percentile 24%
  • IV Rank 22.64%
  • IV High 90.24% on 10/26/20
  • IV Low 45.80% on 06/09/21
  • Put/Call Vol Ratio 0.36
  • Today's Volume 757
  • Volume Avg (30-Day) 1,301
  • Put/Call OI Ratio 0.56
  • Today's Open Interest 6,440
  • Open Int (30-Day) 9,866

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate 0.87
  • Number of Estimates 3
  • High Estimate 0.92
  • Low Estimate 0.82
  • Prior Year 5.68
  • Growth Rate Est. (year over year) -84.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
116.47 +31.13%
on 08/23/21
154.88 -1.39%
on 09/17/21
+33.98 (+28.61%)
since 08/20/21
3-Month
109.75 +39.16%
on 06/22/21
154.88 -1.39%
on 09/17/21
+38.93 (+34.21%)
since 06/18/21
52-Week
103.31 +47.83%
on 06/04/21
288.70 -47.10%
on 11/06/20
-36.58 (-19.32%)
since 09/18/20

Most Recent Stories

More News
3 Diagnostics Stocks in Focus on Biden's Delta Variant Mandate

Stocks like Quest Diagnostics (DGX), Quidel Corporation (QDEL) and LabCorp (LH) are the right picks now, thanks to rising COVID-19 testing demand.

ABT : 124.87 (-1.51%)
LH : 293.91 (-0.68%)
DGX : 154.22 (-0.36%)
QGEN : 54.70 (+0.66%)
QDEL : 152.73 (-0.49%)
Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President's New OSHA Mandates

/PRNewswire/ --   -  More than 80 million workers in are now facing a being pushed by the Biden Administration through the Occupational Safety and Health Administration (OSHA) on employers with +100...

BIOV.CN : 0.490 (-9.26%)
BVAXF : 0.3907 (-7.77%)
QGEN : 54.70 (+0.66%)
ABT : 124.87 (-1.51%)
QDEL : 152.73 (-0.49%)
DGX : 154.22 (-0.36%)
Why New Covid-19 Test Supplies Will Be Needed Soon in Wake of US President’s New OSHA Mandates

VANCOUVER – USA News Group – More than 80 million workers in the United States are now facing ...

QGEN : 54.70 (+0.66%)
ABT : 124.87 (-1.51%)
QDEL : 152.73 (-0.49%)
DGX : 154.22 (-0.36%)
BIOV.CN : 0.490 (-9.26%)
Quidel's (QDEL) QuickVue OTC COVID-19 Test Now Widely Available

In-store and online availability of Quidel's (QDEL) QuickVue OTC COVID-19 Test is expected to meet the rising COVID-19 testing needs across the United States.

HSIC : 75.97 (-1.94%)
CVS : 84.58 (-1.09%)
IDXX : 659.78 (-0.29%)
QDEL : 152.73 (-0.49%)
LivLyme Foundation Founder Olivia Goodreau to Discuss Perils of Lyme Disease in Free Webinar Hosted by Industry-Leading Quidel Corporation

Olivia Goodreau, who founded the LivLyme Foundation at 12 years old and has since become a widely respected advocate and national spokeswoman for Lyme disease prevention and treatment, will discuss her...

QDEL : 152.73 (-0.49%)
Quidel (QDEL) Q2 Earnings Fall Shy of Estimates, Margins Down

Quidel's (QDEL) dismal Q2 performance stems from lower revenues across majority of its product categories.

BIO : 782.52 (-0.74%)
QDEL : 152.73 (-0.49%)
WST : 444.65 (-0.88%)
EHC : 74.48 (-1.90%)
Quidel (QDEL) Q2 Earnings Miss Estimates

Quidel (QDEL) delivered earnings and revenue surprises of -37.50% and 1.91%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

QDEL : 152.73 (-0.49%)
Quidel: Q2 Earnings Snapshot

SAN DIEGO (AP) _ Quidel Corp. (QDEL) on Thursday reported second-quarter profit of $19.1 million.

QDEL : 152.73 (-0.49%)
Quidel (QDEL) to Report Q2 Earnings: What's in the Offing?

Quidel (QDEL) is likely to have registered solid product sales during Q2 which are likely to have driven its overall top line.

AMZN : 3,355.73 (-3.08%)
ILMN : 438.00 (-2.02%)
HSIC : 75.97 (-1.94%)
QDEL : 152.73 (-0.49%)
Quidel Announces Agreement With Beckman Coulter That Terminates Ongoing Litigation and Transitions BNP Business to Beckman Coulter

Quidel Corporation (NASDAQ: QDEL) ("Quidel"), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, today announced its entry into agreements...

QDEL : 152.73 (-0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Quidel Corp. discovers, develops, manufactures and markets point-of-care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout...

See More

Key Turning Points

3rd Resistance Point 160.61
2nd Resistance Point 157.09
1st Resistance Point 154.91
Last Price 152.73
1st Support Level 149.21
2nd Support Level 145.69
3rd Support Level 143.51

See More

52-Week High 288.70
Fibonacci 61.8% 217.88
Fibonacci 50% 196.01
Fibonacci 38.2% 174.13
Last Price 152.73
52-Week Low 103.31

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar